To conclude, we investigated the biological context of the SFRP4 biomarker by using comprehensive spatial and multiomics analysis of heterogenous prostate cancer tissue, an approach not previously applied to analyze SFRP4. This evidence concerns the gene SFRP4 and prostate cancer.